Tuesday, 19 November 2013

From antimicrobial to anticancer peptides

Antimicrobial peptides (AMPs) are part of the innate immune defense mechanism of many organisms. Although AMPs have been essentially studied and developed as potential alternatives for fighting infectious diseases, their use as anticancer peptides (ACPs) in cancer therapy either alone or in combination with other conventional drugs has been regarded as a therapeutic strategy to explore.

This is the basis of an interesting article by Diana Gaspar, and colleagues at the Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal. The article has been published by Frontiers in Microbiology.

The reference is:

Gaspar D, Veiga AS and Castanho MARB (2013) From antimicrobial to anticancer peptides. A review. Front. Microbiol. 4:294. doi: 10.3389/fmicb.2013.00294

Posted by Tim Sandle